Harika Tirumani, MBBS, Michael H

Slides:



Advertisements
Similar presentations
Esophageal Cancer.
Advertisements

Intraductal Papillary Neoplasm of the Bile Duct: Multimodality Imaging Appearances and Pathological Correlation  Csilla Egri, BSc, MSc, Wan Wan Yap, MBChB,
CT and PET imaging in non-small cell lung cancer
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis  Leslie K. Lee, MD, Aoife Kilcoyne,
Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.
Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations  Kate Hanneman, MD, Marie E.
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
Ultrasound, Computed Tomography, and Magnetic Resonance Imaging of Ovarian Vein Thrombosis in Obstetrical and Nonobstetrical Patients  Vivek Virmani,
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Computed Tomography Angiography in Acute Gastrointestinal and Intra-abdominal Bleeding in Children: Preliminary Experience  Dimitri A. Parra, MD, Govind.
Desiree E. Morgan, John C. Texada, Cheri L. Canon, Mark E
Imaging of Ovarian Teratomas in Children: A 9-Year Review
Multimodal Imaging in the Diagnosis of Large Vessel Vasculitis: A Pictorial Review  U. Salati, MBChB, MRCP(UK), Ceara Walsh, MBChB, MRCPI, Darragh Halpenny,
Nonvascular Pediatric Interventional Radiology
Brett W. Carter, MD, Meinoshin Okumura, MD, Frank C
Review of Thoracic Imaging Findings Unique to Women
The Wonderful World of the Windpipe: A Review of Central Airway Anatomy and Pathology  David A. Lawrence, MD, Brittany Branson, MD, Isabel Oliva, MD,
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
Current Status of Breast Ultrasound
Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S
Multidisciplinary Approach to Diagnosis and Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas  Dushyant V. Sahani, Dana J. Lin, Aradhana.
Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.
Inflammatory Pseudotumours in the Abdomen and Pelvis: A Pictorial Essay  Tony Sedlic, MD, Elena P. Scali, MD, Wai-Kit Lee, MD, Sadhna Verma, MD, Silvia.
Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist  Clare Beadsmoore, MBBS, MRCP, FRCR, David Newman, MBBS, FRCR, Duncan.
The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.
Thinking Beyond Peritoneal Carcinomatosis: Imaging Spectrum of Unusual Disseminated Peritoneal Entities  Najla Fasih, MBBS, FRCR, Ram P. Galwa, MD, David.
The Lung Reporting and Data System (LU-RADS): A Proposal for Computed Tomography Screening  Daria Manos, MD, Jean M. Seely, MD, Jana Taylor, MD, Joy Borgaonkar,
Cross-Sectional Imaging of Nontraumatic Peritoneal and Mesenteric Emergencies  Michael N. Patlas, MD, FRCPC, Abdullah Alabousi, MD, Mariano Scaglione,
Extrapulmonary Tuberculosis: Imaging Features Beyond the Chest
Adenocarcinoma arising from cervical esophageal gastric inlet patch
Positron Emission Tomography in Lung Cancer
Annalisa K. Becker, MD, FRCPC, David K. Tso, MD, Alison C
Aysel Türkvatan, MD, Ayşe Erden, MD, Mustafa Seçil, MD, Mehmet A
Abdominal Hemangiomas: A Pictorial Review of Unusual, Atypical, and Rare Types  Vijayanadh Ojili, MD, Sree Harsha Tirumani, MD, Gowthaman Gunabushanam,
Staging of Pancreatic Adenocarcinoma by Imaging Studies
Multimodality Imaging of Tumour Thrombus
Detection of extrathoracic metastases by positron emission tomography in lung cancer  Walter Weder, MD, Ralph A Schmid, MD, Helke Bruchhaus, MD, Sven Hillinger,
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
Cross-Sectional Imaging of Small Bowel Malignancies
Pancreatic and Extrapancreatic Features in Autoimmune Pancreatitis
Carmel G. Cronin, Michael Moore, Michael A. Blake 
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Cross-Sectional Imaging of Small Bowel Malignancies
The Accuracy of Colorectal Cancer Detection by Computed Tomography in the Unprepared Large Bowel in a Community-Based Hospital  Suneet Mangat, MD, Michael.
Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT  Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Abdominal Extraosseous Lesions of Multiple Myeloma: Imaging Findings
Retrospective Review of Efficacy of Radiofrequency Ablation for Treatment of Colorectal Cancer Liver Metastases From a Canadian Perspective  Benjamin.
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia  Rebecca.
Pancreatic Tuberculosis: Role of Multidetector Computed Tomography
Peggy P.W. Yen, BSc, Giles Stevenson, FRCP(C) 
Magnetic Resonance Imaging–Guided Vacuum-Assisted Breast Biopsy: An Initial Experience in a Community Hospital  Paul Friedman, DO, Sean Enis, MD, Jeremy.
How to Approach a Patient With Ampullary Lesion
Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports 
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients with Non-small Cell Lung Cancer in Nonoperable Patients.
Dellano D. Fernandes, MD, FRCPC, Paul B. Shyn, MD, Stuart G
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
Respiratory dynamic magnetic resonance imaging for determining aortic invasion of thoracic neoplasms  Yoo Jin Hong, MD, Jin Hur, MD, Hye-Jeong Lee, MD,
Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing  Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,
Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography  Alex Ryan, MD, Barry.
Axillary Mass and Hypercalcemia: The Value of a Physical Examination
Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT  Maria Victoria Orcurto, MD, Angelika.
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer  Catherine A.B Saunders, Julian.
Pancreatic Tuberculosis: Role of Multidetector Computed Tomography
Fig year-old woman with newly diagnosed inflammatory breast cancer. A-C. Axial fused PET-CT images of supraclavicular region, upper and mid chest.
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States  Megan E. Daly, MD, Julian R.
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography  Kwhanmien Kim, MD, Seung Joon Park,
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management  Harika Tirumani, MBBS, Michael H. Rosenthal, MD, PhD, Sree Harsha Tirumani, MD, Atul B. Shinagare, MD, Katherine M. Krajewski, MD, Nikhil H. Ramaiya, MD  Canadian Association of Radiologists Journal  Volume 66, Issue 2, Pages 130-139 (May 2015) DOI: 10.1016/j.carj.2014.08.006 Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 1 A 60-year-old woman with cervical esophageal cancer. (A) Axial contrast-enhanced computed tomography (CT) image of the chest reveals an intraluminal polypoid mass in the esophageal lumen (arrow). (B) Axial fused fluorodeoxyglucose (FDG) positron emission tomography/CT image demonstrates intense FDG uptake in the esophageal mass (arrow) and a concurrent FDG-avid right supraclavicular node (arrowhead). Endoscopic biopsy of the mass confirmed squamous cell carcinoma. Patient was treated with chemoradiotherapy. (C, D) Axial CT images of the chest 12 months after the treatment demonstrate extensive metastatic bilateral hilar lymphadenopathy (arrows) and metastatic pulmonary nodules (arrowheads). This figure is available in colour online at http://carjonline.org/. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 2 An 82-year-old woman with adenocarcinoma of the distal esophagus. (A-C) Endoscopic ultrasound (EUS) of the esophagus demonstrates a large fungating friable partially obstructing distal esophageal mass (extending between 34 and 41 cm from the incisors), which is hypoechoic with irregular margins (arrow), invasion of the adventitia, and an abnormal enlarged lymph node at 38 cm from the incisors (arrowhead). Biopsy of the mass confirmed adenocarcinoma. Patient was treated with definitive chemoradiation. (D, E) Coronal maximum intensity projection (MIP) images from fluorodeoxyglucose (FDG) positron emission tomography/CT pre- and postchemoradiation demonstrate the distal esophageal mass to be FDG-avid on the pretreatment scan (D) with significant decrease in FDG avidity on the post-treatment scan (E) There is FDG uptake in the esophagus proximal to the tumour and in the stomach. This uptake mimics residual tumour but represents post radiotherapy inflammation, which was confirmed at endoscopic biopsy. This figure is available in colour online at http://carjonline.org/. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 3 A 74-year-old male with midthoracic esophageal carcinoma. (A) Axial contrast-enhanced computed tomography (CT) image of the chest demonstrates circumferential thickening of the esophageal wall (arrow) with loss of fat planes with the bronchi concerning for bronchial invasion (T4b). (B) Follow-up CT shows an esophageal stent with widening of the lumen (arrow). Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 4 A 65-year-old man with gastroesophageal junction (GEJ) adenocarcinoma. (A, B) Axial contrast-enhanced computed tomography (CT) images of the chest demonstrate polypoid thickening of the GEJ (arrow) and a periesophageal node (arrowhead, B) adjacent to the mid thoracic esophagus. (C-E) Axial fused fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT images demonstrate intense FDG uptake in the primary tumour (arrow) as well as the periesophageal node (white arrowhead, D) confirming its metastatic nature. In addition, PET/CT helped in detecting an additional FDG-avid periceliac node (black arrowhead, E). This highlights the ability of PET/CT to accurately stage esophageal cancer. Patient was treated with chemoradiotherapy. During follow-up, he presented with jaundice. (F) Axial contrast-enhanced CT image during the episode of jaundice demonstrates an enhancing nodule at the duodenal ampulla (arrow). (G) Coronal magnetic resonance cholangiopancreatography image demonstrates diffuse biliary dilatation with abrupt cut off at the lower end of common bile duct. Endoscopic retrograde cholangiopancreatography confirmed ampullary metastasis from esophageal adenocarcinoma. This figure is available in colour online at http://carjonline.org/. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 5 A 72-year-old-man with history of chronic lymphocytic leukemia and newly diagnosed gastroesophageal junction (GEJ) adenocarcinoma. (A) Axial contrast-enhanced computed tomography image reveals asymmetric thickening of the GEJ (arrow). Patient underwent esophageal exploration and was found to have unresectable disease. (B) Double-contrast barium esophagogram performed after surgery demonstrates tight irregular stricture at the GEJ (arrow). Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 6 A 40-year-old woman with history of Hodgkin’s disease treated with chemoradiotherapy, presented with extensive liver metastases. Biopsy of the liver lesion showed poorly differentiated carcinoma. Positron emission tomography/computed tomography (PET/CT) was performed to determine the site of the primary tumour. (A, B) Axial fused and coronal maximum intensity projection fluorodeoxyglucose (FDG) PET/CT images demonstrate intensely FDG-avid liver metastases (black arrowheads). There was incidental abnormal uptake in the gastroesophageal junction (GEJ; white arrow). No other site of FDG uptake was noted. (C) Upper gastrointestinal endoscopy demonstrates partially circumferential ulcerating mass at 31-35 cm from the incisors consistent with GEJ tumour. Biopsy confirmed poorly differentiated carcinoma. This figure is available in colour online at http://carjonline.org/. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 7 A 74-year-old woman with midesophageal squamous cell carcinoma. (A) Coronal MIP fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) image demonstrates intensely FDG-avid midesophageal tumour (arrow). There is a mildly FDG-avid right supraclavicular lymph node (arrowhead) but it has uptake less than the primary tumour and therefore most likely inflammatory a reactive rather than a metastatic node. (B) Follow-up PET/CT image after chemoradiotherapy shows significant decrease in the degree and extent of FDG uptake in the primary tumour consistent with treatment response. The right supraclavicular node has resolved. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 8 A 48-year-old-woman with poorly differentiated adenocarcinoma of the esophagus. Coronal contrast-enhanced computed tomography image of the abdomen demonstrates asymmetric thickening of the gastroesophageal junction (arrows), multiple hepatic metastases (black arrowheads), and enlarged metastatic para-aortic nodes (white arrowheads). Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 9 A 71-year-old-man with poorly differentiated adenosquamous carcinoma of the esophagus. Axial contrast-enhanced computed tomography image demonstrates heterogeneous metastatic deposit in a right lower rib as well as ascites consistent with peritoneal carcinomatosis. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Figure 10 A 73-year-old woman with moderately differentiated adenocarcinoma of the esophagus. Axial postgadolinium fat-suppressed T1-weighted magnetic resonance image of the brain demonstrates a large heterogeneously enhancing metastatic deposit in the right parietal lobe (arrows) with midline shift. Canadian Association of Radiologists Journal 2015 66, 130-139DOI: (10.1016/j.carj.2014.08.006) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions